Hector Barajas-Martinez

Dr. Hector Barajas-Martinez

Lankenau Institute for Medical Research, 100 Lancaster Ave, Wynnewood, PA 19096, USA

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2022 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
JBJulien Barc
Julien Barc
RTRafik Tadros
Rafik Tadros
CGCharlotte Glinge
Charlotte Glinge
DCDavid Chiang
David Chiang
MJMariam Jouni
Mariam Jouni
CBConnie Bezzina
Connie Bezzina

4 April 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
JAJuan J. Alvear-Arias
Juan J. Alvear-Arias
CCChristian Carrillo
Christian Carrillo
JVJaviera Paz Villar
Javiera Paz Villar
RGRichard Garcia-Betancourt
Richard Garcia-Betancourt
APAntonio Peña-Pichicoi
Antonio Peña-Pichicoi
CGCarlos Gonzalez
Carlos Gonzalez
Significance: Immunosuppression by myeloid-derived suppressor cells (MDSC), especially near tumor surfaces, involves the extracellular production of reactive oxygen species (ROS). ROS generation in MDSC occurs during the oxidation of NADPH to NADP+, which NOX2 catalyzes. ROS react with the T cell receptor complex, abolishing the antigen presentation, which blocks the immune system elimination of the tumor cells. Extrusion of protons from MDSC by voltage-gated proton channel (Hv1) sustains ROS production. Here, we demonstrate the expression of Hv1 in mouse MDSC. In this way, Hv1 present in MDSC becomes a potential cancer therapeutic target since its inhibition seems to diminish immunosuppression activity in the tumoral microenvironment, allowing cancer cells to be attacked by the immune system.

1 September 2020 in Stem Cells International
Verified
Journal Article
Open access
PDF file
HBHector Barajas-Martinez
Hector Barajas-Martinez
MSMaya Smith
Maya Smith
DHDan Hu
Dan Hu
RGRobert J. Goodrow
Robert J. Goodrow
CPColleen Puleo
Colleen Puleo
Jonathan CordeiroJonathan Cordeiro
Jonathan Cordeiro
Background. We report an inherited cardiac arrhythmia syndrome consisting of Brugada and Early Repolarization Syndrome associated with variants in SCN9A, PXDNL, and FKBP1B. The proband inherited the 3 mutations and exhibited palpitations and arrhythmia-mediated syncope, whereas the parents and sister, who carried one or two of the mutations, were asymptomatic. Methods and Results. We assessed the functional impact of these mutations in induced pluripotent stem cell cardiomyocytes (hiPSC-CMs) derived from the proband and an unaffected family member. Current and voltage clamp recordings, as well as confocal microscopy analysis of Ca2+ transients, were evaluated in hiPSC-CMs from the proband and compared these results with hiPSC-CMs from undiseased controls. Genetic analysis using next-generation DNA sequencing revealed heterozygous mutations in SCN9A, PXDNL, and FKBP1B in the proband. The proband displayed right bundle branch block and exhibited episodes of syncope. The father carried a mutation in FKBP1B, whereas the mother and sister carried the SCN9A mutation. None of the 3 family members screened developed cardiac events. Action potential recordings from control hiPSC-CM showed spontaneous activity and a low upstroke velocity. In contrast, the hiPSC-CM from the proband showed irregular spontaneous activity. Confocal microscopy of the hiPSC-CM of the proband revealed low fluorescence intensity Ca2+ transients that were episodic in nature. Patch-clamp measurements in hiPSC-CM showed no difference in INa but reduced ICa in the proband compared with control. Coexpression of PXDNL-R391Q with SCN5A-WT displayed lower INa density compared to PXDNL-WT. In addition, coexpression of PXDNL-R391Q with KCND3-WT displayed significantly higher Ito density compared to PXDNL-WT. Conclusion. SCN9A, PXDNL, and FKBP1B variants appeared to alter spontaneous activity in hiPSC-CM. Only the proband carrying all 3 mutations displayed the ERS/BrS phenotype, whereas one nor two mutations alone did not produce the clinical phenotype. Our results suggest a polygenic cause of the BrS/ERS arrhythmic phenotype due to mutations in these three gene variants caused a very significant loss of function of INa and ICa and gain of function of Ito.

1 October 2022 in Circulation: Genomic and Precision Medicine
Verified
Journal Article
Closed access
PDF file
DYDan Ye
Dan Ye
WZWei Zhou
Wei Zhou
SHSamantha K. Hamrick
Samantha K. Hamrick
DTDavid J. Tester
David J. Tester
CKC.S. John Kim
C.S. John Kim
MAMichael J. Ackerman
Michael J. Ackerman
Background: The transient outward current (Ito) that mediates early (phase 1) repolarization is conducted by the KCND3 -encoded Kv4.3 pore-forming α-subunit. KCND3 gain-of-function mutations have been reported previously as a pathogenic substrate for J wave syndromes (JWS), including the Brugada syndrome and early repolarization syndrome, as well as autopsy-negative sudden unexplained death (SUD). Acacetin, a natural flavone, is a potent Ito current blocker. Acacetin may be a novel therapeutic for KCND3 -mediated J wave syndrome. Methods: KCND3-V392I was identified in an 18-year-old male with J wave syndrome/early repolarization syndrome, and a history of cardiac arrest including ventricular tachycardia/ventricular fibrillation and atrial fibrillation/atrial flutter. Pathogenic KCND3 mutation was engineered by site-directed mutagenesis and co-expressed with wild-type KChIP2 in TSA201 cells. Gene-edited/variant-corrected isogenic control and patient-specific pluripotent stem cell–derived cardiomyocytes (iPSC-CMs) from the p. Val392Ile-KCND3-positive patient were generated. I to currents and action potentials were recorded before and after treatment with Acacetin using the whole cell patch-clamp and multielectrode array technique. Western blot and immunocytochemistry were performed to investigate KCND3 expression. Results: KCND3-V392I demonstrated a marked gain-of-function phenotype, increasing peak I to current density by 92.2% ( P <0.05 versus KCND3-WT). KCND3 expression was significantly increased in KCND3-V392I-derived iPSC-CMs ( P <0.05 versus isogenic control). While KCND3-WT revealed an IC50 of 7.2±1.0 µmol/L for acacetin effect, 30 µmol/L acacetin dramatically inhibited KCND3-V392I peak Ito current density by 96.2% ( P <0.05 versus before Acacetin). Ito was also increased by 60.9% in Kv4.3-V392I iPSC-CM ( P <0.05 versus isogenic control iPSC-CM). Ten micromoles per liter acacetin, a concentration approaching its IC50 value, inhibited Ito by ≈50% in patient-derived iPSC-CMs and reduced the accentuated action potential notch displayed in KCND3-V392I-derived iPSC-CMs. Conclusions: This preclinical study provides pharmacological and functional evidence to suggest that Acacetin may be a novel therapeutic for patients with KCND3 gain-of-function-associated J wave syndrome by inhibiting I to and abolishing the accentuated action potential notch in patient-derived iPSC-CMs.

1 February 2000 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
PDF file
HBHector Barajas-Martinez
Hector Barajas-Martinez
AEAlejandro Elizalde
Alejandro Elizalde
JSJosé A. Sánchez-Chapula
José A. Sánchez-Chapula
In the present work, we found that the delayed rectifying outward potassium current ( IK) in adult and neonatal cat ventricular myocytes consists of both rapid and slow components, IKrand IKs, respectively, which can be isolated pharmacologically. Thus after complete blockade of IKrwith dofetilide, the remaining IKscurrent is homogeneous, as shown by an envelope of tails test. IKrmaximum tail current density, measured at −40 mV, was similar in adult and neonatal myocytes. IKsmaximum tail current density in neonatal myocytes, measured at −40 mV, was significantly smaller than in adult myocytes. Activation kinetics of IKrand IKswas similar in both age groups. However, the IKrdeactivation time course was significantly faster in neonatal than in adult myocytes. Developmental differences in the subunit composition of IKrthat display distinctly different deactivation kinetics are suggested.

Verified
Journal Article
Open access
PDF file
JTJacqueline A. Treat
Jacqueline A. Treat
RPRyan Pfeiffer
Ryan Pfeiffer
HBHector Barajas-Martinez
Hector Barajas-Martinez
RGRobert Goodrow
Robert Goodrow
CBCorina Bot
Corina Bot
Jonathan CordeiroJonathan Cordeiro
Jonathan Cordeiro
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are used for genetic models of cardiac diseases. We report an arrhythmia syndrome consisting of Early Repolarization Syndrome (ERS) and Short QT Syndrome (SQTS). The index patient (MMRL1215) developed arrhythmia-mediated syncope after electrocution and was found to carry six mutations. Functional alterations resulting from these mutations were examined in patient-derived hiPSC-CMs. Electrophysiological recordings were made in hiPSC-CMs from MMRL1215 and healthy controls. ECG analysis of the index patient showed slurring of the QRS complex and QTc = 326 ms. Action potential (AP) recordings from MMRL1215 myocytes showed slower spontaneous activity and AP duration was shorter. Field potential recordings from MMRL1215 hiPSC-CMs lack a “pseudo” QRS complex suggesting reduced inward current(s). Voltage clamp analysis of ICa showed no difference in the magnitude of current. Measurements of INa reveal a 60% reduction in INa density in MMRL1215 hiPSC-CMs. Steady inactivation and recovery of INa was unaffected. mRNA analysis revealed ANK2 and SCN5A are significantly reduced in hiPSC-CM derived from MMRL1215, consistent with electrophysiological recordings. The polygenic cause of ERS/SQTS phenotype is likely due to a loss of INa due to a mutation in PKP2 coupled with and a gain of function in IK,ATP due to a mutation in ABCC9.